Omicron COVID-19 Variant: Pfizer, BioNTech Unsure About Vaccine Efficacy Against New Variant
Kort samengevat
Noting that they are not sure whether their vaccines would work against new COVID-19 variant 'Omicron, Pfizer and BioNTech promised to develop a new vaccine against the strain within 100 days.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Indiatimes.
Lees het volledige bericht ↗